GH Research (GHRS)
NASDAQ: GHRS
· Real-Time Price · USD
12.87
0.11 (0.86%)
At close: Jun 16, 2025, 3:59 PM
12.72
-1.17%
After-hours: Jun 16, 2025, 04:04 PM EDT
0.86% (1D)
| Bid | 12.4 |
| Market Cap | 798.3M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -42.11M |
| EPS (ttm) | -0.79 |
| PE Ratio (ttm) | -16.29 |
| Forward PE | -8.32 |
| Analyst | Buy |
| Ask | 13.95 |
| Volume | 214,704 |
| Avg. Volume (20D) | 183,576 |
| Open | 12.80 |
| Previous Close | 12.76 |
| Day's Range | 12.48 - 13.15 |
| 52-Week Range | 6.00 - 20.50 |
| Beta | 0.97 |
About GHRS
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol GHRS
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for GHRS stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts4 months ago
-9.28%
GH Research shares are trading lower after announc...
Unlock content with
Pro Subscription
4 months ago
+69.72%
GH Research shares are trading higher after the company's inhalable depression treatment GH001 met the primary endpoint in its Phase 2b trial, showing symptom reduction.
